• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ATRIUM MEDICAL CORPORATION ICAST COVERED STENT; PTFE COVERED STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ATRIUM MEDICAL CORPORATION ICAST COVERED STENT; PTFE COVERED STENT Back to Search Results
Model Number 85444
Device Problem Detachment Of Device Component (1104)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 08/24/2017
Event Type  Injury  
Manufacturer Narrative
On completion of the investigation a follow up report will be submitted.
 
Event Description
The procedure was a percutaneous 4 vessel fenestrated endovascular aortic aneurysm repair.The stent came off the balloon after insertion into patient.Stent and balloon both were retrieved successfully and returned to the sterile field.
 
Manufacturer Narrative
Medwatch received: (b)(4).
 
Event Description
Medwatch received: (b)(4).
 
Manufacturer Narrative
Engineering investigation: the returned device was evaluated to determine the cause of the complaint.Upon inspection the stent was no longer on the balloon and had been flattened.The balloon was still in the folded position and showed no signs of positive pressure.The balloon surface was evaluated to determine if the stent was crimped properly during manufacturing.When a stent is crimped on to the folded balloon the stent frame leaves impressions of the stent frame on the surface of the balloon.The impressions indicate if the stent was properly crimped on to the balloon.The crimped stent impressions were clearly visible indicating that the stent was properly crimped during manufacturing.A full review of the catheter lot history records for the devices in question was performed.The records indicate that this lot of catheters passed atriums final lot qualification testing.This inspection requires that the catheter lot must pass the following: ability of the stent and delivery system to be passed through the labeled introducer sheath.Ability to deploy the stent at nominal pressure (8atm).Ability to withdraw the deflated balloon catheter back through the labeled introducer sheath ability of the delivery system to withstand 5 inflate/deflate cycles at the rated burst pressure (12atm) without leaks or failures.Balloon burst testing.The balloon must burst over the rated burst pressure specified on the label (12atm) result: all quality inspection samples passed this final inspection without any non-conformances noted during the final lot qualification testing associated with the complaint.There were no issues in regards to the stents being able to pass through the introducer sheath.In addition to the final lot qualification testing there are multiple in-process inspections conducted that include the following: balloon hole skive dimensional verification.Stent securement testing.Proximal balloon weld tensile testing.Distal tip tensile testing.Catheter leak check result: all quality inspection samples passed this final inspection without any non-conformances noted during the final lot qualification testing.The in-process test data shows that the minimum stent dislodgement force was over 8.5 newtons (n).This is well over the minimum requirement of 5.5n.Conclusion: based on the details of the event and the successful lot qualification test data, atrium can find no fault with the lot of stent delivery systems in question.Clinical evaluation: endovascular aortic aneurysm repair (evar) is a minimally invasive procedure that is used to treat an abdominal aortic aneurysm.The procedure includes placement of a large endograft within the aorta and stent placement into the adjacent arteries as protection from occlusion by the graft.The graft is then secured via fixation barbs to prevent migration.A stent can become dislodged if the vessel has calcification or severe disease, if the vessel has not been properly pre-dilated, if the stent or sheath has not been sized correctly or if the physician uses force to advance or withdraw the catheter.A stent may migrate due to inadequate implantation at the target site.If a stent migrates it may result in the need for surgical or interventional revision to prevent thrombus formation, ischemia, vascular occlusion and pain.The instructions for use (ifu) warn that inadvertent, partial, or failed deployment or migration of the device may require surgical intervention.The ifu also notes that complications and adverse events can occur when using any endoluminal device.These include, but are not limited to: misplacement, migration, infection, septic shock, occlusion, perforation or hemorrhage.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ICAST COVERED STENT
Type of Device
PTFE COVERED STENT
Manufacturer (Section D)
ATRIUM MEDICAL CORPORATION
40 continental blvd
merrimack 03054
Manufacturer (Section G)
ATRIUM MEDICAL CORPORATION
40 continental blvd
merrimack 03054
Manufacturer Contact
lynda mclaughlin
40 continental blvd
merrimack, NH 03054
MDR Report Key6861003
MDR Text Key85908378
Report Number3011175548-2017-00121
Device Sequence Number1
Product Code JCT
UDI-Device Identifier00650862854442
UDI-Public00650862854442
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K050814
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Nurse
Type of Report Initial,Followup,Followup
Report Date 09/11/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date03/22/2020
Device Model Number85444
Device Catalogue Number85444
Device Lot Number249080
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/20/2017
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 09/07/2017
Initial Date FDA Received09/13/2017
Supplement Dates Manufacturer Received09/29/2017
10/17/2017
Supplement Dates FDA Received10/02/2017
10/24/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/22/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age69 YR
Patient Weight79
-
-